228 related articles for article (PubMed ID: 21425444)
21. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia.
Masaoka T; Ogawa M; Yamada K; Kimura K; Ohashi Y
Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of acute myeloid leukemia].
Obrecht JP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):190-200. PubMed ID: 6208102
[No Abstract] [Full Text] [Related]
23. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
[TBL] [Abstract][Full Text] [Related]
24. Ominous cutaneous presentation of acute myeloid leukemia without peripheral blood involvement upon initial presentation and relapse: case report and literature review.
Elkeeb D; Hopkins Z; Miles RR; Halwani A; Wada D
Eur J Dermatol; 2018 Dec; 28(6):809-817. PubMed ID: 30698150
[TBL] [Abstract][Full Text] [Related]
25. Monocytic aleukemic leukemia cutis.
Török L; Lueff S; Garay G; Tápai M
J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):54-8. PubMed ID: 10565632
[TBL] [Abstract][Full Text] [Related]
26. Aleukemic leukemia cutis presenting as benign-appearing exanthema.
Benez A; Metzger S; Metzler G; Fierlbeck G
Acta Derm Venereol; 2001; 81(1):45-7. PubMed ID: 11411915
[TBL] [Abstract][Full Text] [Related]
27. Pediatric aleukemic leukemia cutis: report of 3 cases and review of the literature.
Gru AA; Coughlin CC; Schapiro ML; Lombardi M; Martin A; Bayliss SJ; Frater J; Dehner LP
Am J Dermatopathol; 2015 Jun; 37(6):477-84. PubMed ID: 25148106
[TBL] [Abstract][Full Text] [Related]
28. Aleukemic leukemia cutis.
Hansen RM; Barnett J; Hanson G; Klehm D; Schneider T; Ash R
Arch Dermatol; 1986 Jul; 122(7):812-4. PubMed ID: 3729513
[TBL] [Abstract][Full Text] [Related]
29. Aleukemic monocytic leukemia cutis.
Barzilai A; Lyakhovitsky A; Goldberg I; Meytes D; Trau H
Cutis; 2002 Apr; 69(4):301-4. PubMed ID: 12080951
[TBL] [Abstract][Full Text] [Related]
30. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
31. A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage. A pilot study.
Kuriya S; Murai K; Miyairi Y; Utsugisawa T; Narigasawa Y; Ito T; Shimosegawa K; Ishida Y
Cancer; 1996 Aug; 78(3):422-6. PubMed ID: 8697386
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous resolution of a single lesion of myeloid leukemia cutis in an infant: case report and discussion.
D'Orazio JA; Pulliam JF; Moscow JA
Pediatr Hematol Oncol; 2008 Jun; 25(5):457-68. PubMed ID: 18569848
[TBL] [Abstract][Full Text] [Related]
33. Risk-adapted induction and consolidation therapy in adults with de novo AML aged Heil G; Krauter J; Raghavachar A; Bergmann L; Hoelzer D; Fiedler W; Lübbert M; Noens L; Schlimok G; Arnold R; Kirchner H; Ganser A
Ann Hematol; 2004 Jun; 83(6):336-44. PubMed ID: 15034758
[TBL] [Abstract][Full Text] [Related]
34. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
35. Isolated leukemia cutis--a case report.
Haubenstock A; Zalusky R; Ghali VS; Mernick MH; Malamud SC; Stein JJ
Am J Hematol; 1987 Apr; 24(4):437-9. PubMed ID: 3471086
[TBL] [Abstract][Full Text] [Related]
36. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
[TBL] [Abstract][Full Text] [Related]
37. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
Fière D; Bryon PA; Martin C; Revol L
Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
[No Abstract] [Full Text] [Related]
38. [Neonatal monoblastic leukemia revealed by transitory specific skin lesions].
Rybojad M; Bredoux H; Vignon-Pennamen MD; Prigent F; Morel P; Bourrat E
Ann Dermatol Venereol; 1999 Feb; 126(2):157-9. PubMed ID: 10352833
[TBL] [Abstract][Full Text] [Related]
39. Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.
Bezerra MF; Coelho-Silva JL; Nascimento JC; Benicio MT; Rocha CR; Machado CG; Rego EM; Bezerra MA; Lucena-Araujo AR; Beltrão EI
Haematologica; 2017 Feb; 102(2):e43-e46. PubMed ID: 27846614
[No Abstract] [Full Text] [Related]
40. Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.
Sait S; Kobos R; LaQuaglia MP; Pandit-Taskar N; Modak S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27804217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
